Tecan UK Ltd

Activities: Manufacturing Analysis

Trending Articles

  1. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  2. Fasenra for EGPA: addressing unmet needs Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  5. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Analysis

Diagnosing hormone-based disorders using saliva

Diagnosing hormone-based disorders using saliva samples dates back to the 1980s; however, it’s only the sensitivity improvements that have occurred during the last decade that have led to saliva-based diagnostics becoming a viable alternative to blood testing
Manufacturing

Tecan and DYNEX partner on ELISA products in US

Customers will now have direct access to Tecan’s ELISA-related kits and comprehensive portfolio of reagents alongside DYNEX's fully automated ELISA workstations
Research & Development

Investigating DNA repair inhibitors to treat cancer and other inflammatory diseases

Many current chemotherapy drugs work by causing replication-associated DNA damage that kills individual cancer cells. However, as well as destroying the cells responsible for the disease, the drugs often also indiscriminately affect healthy cells, causing unpleasant side-effects for the patient
Research & Development

Tecan launches benchtop system for NGS library prep

The system is designed to simplify the preparation of samples for sequencing
Subscribe now